ArticleGynecologic oncology reports2025
Unusual metastatic pattern of endometrial carcinoma with distal foot involvement.
Article in Gynecologic oncology reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Endometrial carcinoma typically metastasizes to the lungs, liver, and bones of the axial skeleton. Metastatic spread to the bones of the foot is exceedingly rare and may present with nonspecific musculoskeletal symptoms, often mimicking infection. Recognizing such atypical metastatic patterns is essential for timely diagnosis and management, particularly in patients with high-risk disease. Case report: A 62-year-old woman with FIGO stage IIIB endometrioid adenocarcinoma, previously treated with surgery and radiotherapy, presented with progressive pain and swelling of the right foot. Initial clinical evaluation suggested cellulitis, and empiric antibiotics were started. Symptoms persisted, prompting further investigation. MRI demonstrated diffuse marrow abnormalities and cortical disruption in multiple tarsal bones, raising suspicion for malignancy. Biopsy confirmed metastatic endometrioid adenocarcinoma. FDG PET-CT revealed intense uptake in the foot lesion, as well as additional FDG-avid lesions in the right femur, fibula, metatarsal, and a pulmonary nodule, consistent with widespread metastatic disease. Conclusion: Metastases to the bones of the foot from endometrial carcinoma are rare and can mimic infection. This case highlights the importance of maintaining a high index of suspicion for unusual metastatic patterns in patients with persistent musculoskeletal symptoms and a history of high-risk endometrial cancer. Timely imaging and histologic confirmation are critical for accurate diagnosis and appropriate management, especially as such presentations often indicate advanced systemic disease.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.